/PRNewswire/ The "Global Dermatology Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com s offering..
Oncorus (NASDAQ:ONCR – Get Rating) and Hoth Therapeutics (NASDAQ:HOTH – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Volatility and Risk Oncorus has a beta of 4.27, meaning […]